القناة الشريانية

يؤدي عدم انغلاق القناة الشريانية بعد الولادة إلى حالة تُسمى القناة الشريانية السالكة ، والتي ينتج عنها تدفق غير طبيعي للدم من الأبهر إلى الشريان الرئوي: تحويلة من اليسار إلى اليمين . إذا تُركت هذه الحالة دون علاج، فإنها عادةً ما تؤدي إلى ارتفاع ضغط الدم الرئوي، يليه قصور في البطين الأيمن للقلب ، بالإضافة إلى احتمالية حدوث اضطرابات في نظم القلب .

The "E" series of prostaglandins are responsible for maintaining the openness of the ductus arteriosus (by dilation of vascular smooth muscle) throughout the fetal period.^[3] Prostaglandin E2 (PGE₂), produced by both the placenta and the DA itself, is the most potent of the E prostaglandins, but prostaglandin E1 (PGE₁) also has a role in keeping the DA open.^[4] PGE₁ and PGE₂ keep the ductus arteriosus open via involvement of specific PGE-sensitive receptors (such as EP4 and EP2).^[5] EP4 is the major receptor associated with PGE₂-induced dilation of the DA and can be found across the DA in smooth muscle cells.^[6] Immediately after birth, the levels of both PGE₂ and the EP4 receptors reduce significantly, allowing for closure of the DA and establishment of normal postnatal circulation.^[6]

Ductus arteriosus closure may be induced by administration of nonsteroidal anti-inflammatory drugs (NSAIDs), which inhibit prostaglandin production.^[4] The most common NSAID used is Indomethacin, which is usually administered in the first week after birth.^[4] However, in the presence of a congenital defect with impaired lung perfusion (e.g. Pulmonary stenosis and left-to-right shunt through the ductus), it may be advisable to improve oxygenation by maintaining the ductus open with prostaglandin treatment. However, such treatments are ineffective in an abnormal ductus. Persistence of the ductus may be associated with other abnormalities, and is much more common in females. By inhibiting PGE₂ formation, EP4 receptor activation will decrease and normal circulation can begin. NSAIDs taken late in pregnancy can cross the placenta and lead to premature closure of the DA in the fetus.^[7] In this case, exogenous PDE₂ can be administered to reverse the effects of the NSAIDs and maintain the patency of the DA for the remainder of the pregnancy.^[4]

A patent ductus arteriosus affects approximately 4% of infants with Down syndrome (DS). A failure to thrive is a very common sign of this condition.^[8]

في بعض أنواع عيوب القلب الخلقية (مثل تبدل الشرايين الكبيرة )، يمكن إعطاء البروستاجلاندينات للحفاظ على القناة الشريانية مفتوحة، مما يسمح باستمرار دوران الدم وتأكسجه، إلى حين إجراء الجراحة. ^{[ 9 ]}